logo
  

Johnson & Johnson Boosts FY20 Outlook - Quick Facts

While reporting financial results for the second quarter, healthcare company Johnson & Johnson (JNJ) on Thursday raised its earnings and sales forecast for the full year 2020.

For fiscal 2020, the company now projects adjusted earnings in a range of $7.75 to $7.95 per share and adjusted operational earnings in a range of $7.85 to $8.05 per share.

The company previously expected adjusted earnings in the range of $7.50 to $7.90 per share and adjusted operational earnings in the range of $7.65 to $8.05 per share.

Additionally, the company now projects reported sales between $79.9 billion and $81.4 billion, operational sales between $81.0 billion and $82.5 billion and adjusted operational sales change between a decline of 0.8 percent and a growth of 1.0 percent.

Earlier, the company forecast reported sales between $77.5 billion and $80.5 billion, operational sales between $79.2 billion and $82.2 billion and adjusted operational sales change between a decline of 3.0 percent and a growth of 0.5 percent.

On average, 19 analysts polled by Thomson Reuters expect the company to report earnings of $7.73 per share on a revenue decline of 3.1 percent to $79.54 billion. Analysts' estimates typically exclude special items.

"Our second quarter results reflect the impact of COVID-19 and the enduring strength of our Pharmaceutical business, where we saw continued growth even in this environment," said Alex Gorsky, Chairman and Chief Executive Officer.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Goldman Sachs Group, Inc. (GS) reported that its third quarter net earnings applicable to common shareholders increased 63 percent year-on-year. Net revenues were also significantly higher reflecting significantly higher net revenues in Investment Banking, Global Markets and Consumer & Wealth Management,... Butterball, LLC recalled about 14,107 pounds of ground turkey products for potential contamination with foreign materials, specifically blue plastic material, the U.S. Department of Agriculture's Food Safety and Inspection Service (FSIS) said in a statement. Specialized Bicycle Components, Inc. is recalling about 6,900 units of Tarmac SL7 Bicycles and Framesets for potential risk of fall and injury hazard, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said the bicycle's fork steerer tube can crack or break after harsh impact such as hitting a deep pothole or other stress event, posing fall and injury hazards.
Follow RTT